Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Vascular Endothelial Growth Factor
100%
Metastatic Lesions
100%
Early Metastatic
100%
Hematopoietic Stem Cells
66%
Metastatic Disease
25%
Tracer Uptake
25%
Metastatic Dissemination
25%
Patient Demographics
8%
Uptake Studies
8%
Enhanced Expression
8%
Retargeting
8%
Targeted Molecular Imaging
8%
Metastatic Activity
8%
Longitudinal PET
8%
Major Player
8%
Heterogeneous Population
8%
Effective Treatment
8%
Bone Marrow
8%
Tumor-like Lesions
8%
Non-invasive Imaging
8%
Metastasis
8%
Receptor Binding
8%
Zirconium-89 (89Zr)
8%
Specific Antibodies
8%
Internalization Mechanism
8%
Breast Cancer Tumor
8%
First Goal
8%
Pro-metastatic
8%
Therapeutic Interventions
8%
Cause of Death
8%
Published Results
8%
Pre-metastatic Niche
8%
Tumor Cell Lines
8%
Immunosuppressive Microenvironment
8%
Primary Tumor
8%
Specific Uptake
8%
Selective Ligands
8%
Imaging Studies
8%
Pre-metastatic
8%
Expression Level
8%
Receptor Internalization
8%
Intracardiac Injection
8%
Breast Carcinoma
8%
PET Imaging
8%
Metastasis Cascade
8%
Visceral Organs
8%
Invasion-metastasis Cascade
8%
Methods for Detection
8%
V-model
8%
Dose-dependent
8%
Murine Breast Cancer
8%
Early Metastasis
8%
Metastatic Growth
8%
Metastasis Model
8%
Non-invasive Method
8%
Breast Cancer Patients
8%
Well-defined
8%
Imaging Approach
8%
Pro-tumorigenic
8%
Copper-catalyzed Azide-alkyne Cycloaddition (CuAAC)
8%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin Receptor 1
100%
Receptor
36%
Tracer
36%
Prevalence
18%
Breast Cancer
18%
Polyethylene Terephthalate
18%
Neoplasm
9%
Intracardiac Injection
9%
Fluorine 18
9%
Breast Carcinoma
9%
Immunosuppressive Agent
9%
Primary Tumor
9%
Vasculotropin
9%
Zirconium 89
9%
Click Chemistry
9%
Immunology and Microbiology
Vasculotropin
100%
Hematopoietic Cell
66%
Positron Emission Tomography
16%
Prevalence
16%
Tumor Cell Line
8%
Click Chemistry
8%
Molecular Imaging
8%
Internalization
8%
Immunosuppressive Drug
8%
Receptor Binding
8%